newsfilter
← Latest News
GlobeNewswire·

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

–Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for